We only have been authorized 400 terms in that letter, however, if I was provided A further 400, I'd argue that what we need to be carrying out is comparative performance research and never double blind placebo Management trials for Prolotherapy because any injection Handle will probably have All those problems. Comparative usefulness exploration i